The Oncology Institute to Open Project Southland
The Oncology Institute to Open Project Southland
TOI acquires SRON and expands radiation oncology services in the Greater LA area
TOI收購SRON並在大洛杉磯地區擴大放射腫瘤學服務
CERRITOS, Calif., June 07, 2023 (GLOBE NEWSWIRE) -- The Oncology Institute (NASDAQ: TOI), has announced a strategic acquisition that aims to further consolidate the Greater Los Angeles market and establish the company as one of the largest value-based community oncology groups in the United States. The acquisition of Southland Radiation Oncology Network (SRON) will amplify TOI's radiation oncology market presence by five additional clinics across the eastern San Gabriel Valley and Inland Empire, providing TOI with a distinct advantage over local private practices and tertiary centers.
加利福尼亞州塞裡託斯，2023年6月7日(環球社)--腫瘤學研究所(納斯達克：TOI)宣佈了一項戰略收購，旨在進一步鞏固大洛杉磯市場，並將公司打造為美國最大的基於價值的社區腫瘤學集團之一。收購Southland放射腫瘤學網路(SRON)將通過在聖加布裡埃爾河谷東部和內陸帝國增加五家診所，擴大TOI的放射腫瘤學市場份額，使TOI擁有相對於當地私人診所和三級中心的獨特優勢。
The acquisition of SRON is an important milestone for TOI as they continue to expand their ability to provide complete population health for oncology care. It will enable broader coverage across the Los Angeles area, providing more access to life-saving care for those who may not be able to otherwise afford treatment or transportation.
收購SRON對TOI來說是一個重要的里程碑，因為他們繼續擴大自己的能力，為腫瘤護理提供完整的人群健康。它將使洛杉磯地區得到更廣泛的覆蓋，為那些否則可能負擔不起治療或交通費用的人提供更多獲得救命護理的機會。
"We are thrilled to be taking this next step in our journey as we expand our radiation oncology practice locations, and look forward to serving the community with the highest quality of care," said Dan Virnich, MD, MBA, FACHE, President of The Oncology Institute. "This acquisition aligns with our strategic vision to be the leading value-based cancer care group in the U.S., and demonstrates our commitment to delivering comprehensive oncology solutions that will benefit our patients and the broader community."
腫瘤學研究所的丹·維尼奇、醫學博士、工商管理碩士、法希和總裁說：“我們很高興能在我們的旅程中邁出下一步，擴大我們的放射腫瘤學實踐地點，並期待著以最高質量的護理服務社區。此次收購符合我們成為美國領先的基於價值的癌症護理集團的戰略願景，並表明我們致力於提供全面的腫瘤學解決方案，使我們的患者和更廣泛的社區受益。“
The acquisition of SRON will enable TOI to offer value-based radiation oncology care to more patients in the Greater Los Angeles area.
收購SRON將使TOI能夠為大洛杉磯地區的更多患者提供基於價值的放射腫瘤學護理。
About TOI
Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.8 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 100+ employed clinicians and more than 700 teammates in over 60 clinic locations and growing, TOI is changing oncology for the better. For more information visit .
關於TOI
TOI成立於2007年，通過在社區環境中提供高度專業化的、基於價值的癌症護理來推動腫瘤學的發展。TOI為大約180萬患者提供基於證據的尖端癌症護理，包括臨床試驗、輸血和其他傳統上與最先進的護理提供機構相關的護理提供模式。TOI擁有100多名受僱的臨床醫生和700多名隊友，分佈在60多個診所，而且人數還在不斷增加，TOI正在讓腫瘤學變得更好。有關更多資訊，請訪問。
Contacts
Contacts
Media
媒體
The Oncology Institute, Inc.
Daniel Virnich, MD
danielvirnich@theoncologyinstitute.com
(562) 735-3226 x 81125
腫瘤研究所，Inc.
Daniel·維尼奇，醫學博士
郵箱：danielvirnich@theoncologyInstitute te.com
(562)735-3226x 81125
Investors
投資者
Solebury Strategic Communications
investors@theoncologyinstitute.com
索爾伯裡戰略通信
郵箱：Investors@theoncologyInstitute te.com
譯文內容由第三人軟體翻譯。